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It is encouraging to see the Royal College of Speech and
Language Therapists supporting randomised controlled trials
(RCTs).1 2 Meteyard worries that RCTs will not cope with the
complexity inherent after stroke.3 However, many RCTs have
demonstrated the effectiveness of a range of complex
interventions for heterogeneous populations (for example, stroke
unit care, occupational therapy).
As Enderby notes, the Cochrane review finds benefit of therapy
compared with nothing. However, like us it also finds no benefit
over attention control.4 So “some is better than none,”5 but we
must be open minded about what is done and by whom. Despite
Meteyard’s concerns we can rule out those activities provided
only to the intervention group (such as one to one impairment
based therapy). In the first four months of stroke they added
nothing to the outcome for participants from any measured
perspective.1
Meteyard is wrong to say that treatment was unconstrained and
that we examined variation in current practice. Each site altered
its previous practice by adopting manualised assessment and
treatment pathways, tools, and techniques as agreed by
consensus. As Enderby recommends, our therapists targeted
therapy to those most likely to benefit and selected appropriately
tailored interventions.
We are grateful to Enderby for quoting our cautionary warnings
about misinterpreting the findings, especially given Thornton’s
reaction.6 Our nested qualitative study showed people with
stroke valued increased early support (regardless of whether
therapy or control).7 Interaction with a good communicator may
be as beneficial as formal therapy. We recommend evaluating
reorganised early services that retain therapists to supervise
increased time with less qualified staff, with therapists directly
involved for persisting problems.
In response to Thornton,6 the funding supported a series of
studies with more than 700 participants, including studies on
developing patient centred outcome measures that have had
good international uptake.8 9
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